Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences. | Cancers (Basel) | 2023 | 37345032 | PubTator, text mining | PubMed |
| Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types. | bioRxiv | 2023 | 37333155 | PubTator, text mining | PubMed |
| Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. | Nat Commun | 2023 | 37328470 | PubTator, text mining | PubMed |
| Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor. | Oncologist | 2023 | 37315115 | PubTator, text mining | PubMed |
| A new tumorgraft panel to accelerate precision medicine in prostate cancer. | Front Oncol | 2023 | 37305585 | PubTator, text mining | PubMed |
| Insulin-Like Growth Factor1 Preserves Gastric Pacemaker Cells and Motor Function in Aging via ERK1/2 Activation. | Cell Mol Gastroenterol Hepatol | 2023 | 37301443 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. | Int J Mol Sci | 2023 | 37298233 | PubTator, text mining | PubMed |
| Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy. | Cancers (Basel) | 2023 | 37296931 | PubTator, text mining | PubMed |
| Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity. | Hum Genomics | 2023 | 37287057 | PubTator, text mining | PubMed |
| Single-cell analysis reveals dysregulated inflammatory response in peripheral blood immunity in patients with acute respiratory distress syndrome. | Front Cell Dev Biol | 2023 | 37283946 | PubTator, text mining | PubMed |
| Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. | Pharmaceuticals (Basel) | 2023 | 37259439 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| The Interplay between T Cells and Cancer: The Basis of Immunotherapy. | Genes (Basel) | 2023 | 37239368 | PubTator, text mining | PubMed |
| Characterization of BoHV-4 ORF45. | Front Microbiol | 2023 | 37234529 | PubTator, text mining | PubMed |
| Nkx2-5 Loss of Function in the His-Purkinje System Hampers Its Maturation and Leads to Mechanical Dysfunction. | J Cardiovasc Dev Dis | 2023 | 37233161 | PubTator, text mining | PubMed |
| Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases. | Neuroendocrinology | 2023 | 37232011 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Cortical interneurons: fit for function and fit to function? Evidence from development and evolution. | Front Neural Circuits | 2023 | 37215503 | PubTator, text mining | PubMed |
| Ubiquitin-independent proteasomal degradation driven by C-degron pathways. | Mol Cell | 2023 | 37201526 | PubTator, text mining | PubMed |
| Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses. | Front Oncol | 2023 | 37197420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=11